Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stuart

Showing results (391-400 of 469) with videos related to

Pageof 47
Sort By:
The American Surgeon|July 1, 1987
Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allograftsA O Gaber, J R Thistlethwaite, B W Haag, et al.
Psychological Medicine|September 26, 2018
Deficient auditory predictive coding during vocalization in the psychosis risk syndrome and in early illness schizophrenia: the final expanded sampleDaniel H Mathalon, Brian J Roach, Jamie M Ferri, et al.
Biochemical Society Transactions|October 25, 2000
Genomic organization and gene function in LeishmaniaP J Myler, E Sisk, P D McDonagh, et al.
The Journal of Biological Chemistry|August 26, 1998
Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperonesJ K Stuart, D G Myszka, L Joss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsJason M God, Christine Cameron, Janette Figueroa, et al.
Transplantation Proceedings|February 1, 1987
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporineJ R Thistlethwaite, B W Haag, A O Gaber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumorsK N Bhalla, G N Kumar, U K Walle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
Characterization of a highly polymorphic marker adjacent to the SLC4A1 gene and of kidney immunostaining in a family with distal renal tubular acidosisChairat Shayakul, Petr Jarolim, Marie Zachlederova, et al.
Frontiers in Microbiology|August 23, 2013
Impact of DNA damaging agents on genome-wide transcriptional profiles in two marine Synechococcus speciesSasha G Tetu, Daniel A Johnson, Deepa Varkey, et al.
Medical Oncology (Northwood, London, England)|March 14, 2000
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trialA A Ezzat, E M Ibrahim, R K Stuart, et al.
Pageof 47

Showing results (391-400 of 469) with videos related to

Sort By:
Pageof 47
The American Surgeon|July 1, 1987
Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allograftsA O Gaber, J R Thistlethwaite, B W Haag, et al.
Psychological Medicine|September 26, 2018
Deficient auditory predictive coding during vocalization in the psychosis risk syndrome and in early illness schizophrenia: the final expanded sampleDaniel H Mathalon, Brian J Roach, Jamie M Ferri, et al.
Biochemical Society Transactions|October 25, 2000
Genomic organization and gene function in LeishmaniaP J Myler, E Sisk, P D McDonagh, et al.
The Journal of Biological Chemistry|August 26, 1998
Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperonesJ K Stuart, D G Myszka, L Joss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsJason M God, Christine Cameron, Janette Figueroa, et al.
Transplantation Proceedings|February 1, 1987
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporineJ R Thistlethwaite, B W Haag, A O Gaber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumorsK N Bhalla, G N Kumar, U K Walle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
Characterization of a highly polymorphic marker adjacent to the SLC4A1 gene and of kidney immunostaining in a family with distal renal tubular acidosisChairat Shayakul, Petr Jarolim, Marie Zachlederova, et al.
Frontiers in Microbiology|August 23, 2013
Impact of DNA damaging agents on genome-wide transcriptional profiles in two marine Synechococcus speciesSasha G Tetu, Daniel A Johnson, Deepa Varkey, et al.
Medical Oncology (Northwood, London, England)|March 14, 2000
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trialA A Ezzat, E M Ibrahim, R K Stuart, et al.
Pageof 47